The three-story 20 Walkup Dr. building, which the firm willoccupy fully, will serve both as RenaMed's headquarters and thecommercial manufacturing facility for its Renal Bio-ReplacementTherapy products for Acute Renal Failure. Terms of the long-termlease were not disclosed.

Joe Flynn, vice president at NAI Hunneman Commercial,represented RenaMed Biologics. Brian McKenzie, John Lashar and PaulLeone of Richards Barry Joyce & Partners represented thebuilding's landlord, Campanelli Cos..

Richard Andrews, senior business manager for the firm, tellsGlobeSt.com that the company selected the site because it offered astrong production component with a clean-room infrastructure thatcan handle the company's increasing operational needs.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.